Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

ESMO Congress 2022

09 - 13 Sep 2022

Paris, France

ESMO-Congress-2022-1000x1000

Resources are available according to the presenters' agreement to release them.

Abstracts and ePosters are open access.
Slides and webcasts are reserved to registered Delegates (6 months) and ESMO Members.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

Meeting programme Next/upcoming meetings
Understanding the disease to provide better CARE for #cancer patients

Practice changing data and high quality education in more than 20 tracks covering all tumour types, therapeutic innovations, translational research, patient advocacy, public policy, and more...

Congress coverage: Expert video reports  |  Highlight videos

Twelve ESMO Congress 2022 breakthroughs: practicing oncologists’ perceptions and potential application on presented data
Published in ESMO Open, on behalf of the Practising Oncologists Working Group

Quick access to special sessions

Open access - Clinical Practice Guidelines session 1 (eBC, CUP, Biliary tract)

Open access - Clinical Practice Guidelines session 2 (Bladder, CNS Lymphoma, mNSCLC)

ESMO Colloquia

Hide
Filter by:
Search:
Reset

There are 2867 resources available

Conclusion and Q&A

Presenter: Julien Taieb

Session: Servier - Interpreting real-world data to better manage patients with metastatic colorectal cancer

Resources:

Webcast

Conclusion

Presenter: Allan Hackshaw

Session: F. Hoffman-La Roche LTD - Navigating the possibilities of personalised healthcare in oncology

Resources:

Webcast

Introduction and scientific background

Presenter: Eva Ciruelos

Session: Antibody-drug conjugates to transform outcome of patients with metastatic breast cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.